Topamax (topiramate) is used for the treatment of epilepsy, migraine headaches and weight loss (as half of the new weight loss drug Qsymia). Now, there is a new long-acting Topamax called Trokendi XR.
• Trokendi XR has been approved, for now, only as an anti-epileptic drug indicated for treatment in patients 10 years of age and older with partial onset or primary generalized tonic-clonic seizures.
• It’s available in 25mg, 50mg, 100mg, and 200mg extended-release capsules.
• We don’t know or think it’s any better than Topamax but it may have easier once daily dosing.
Trokendi XR will start from around $180 for 30 capsules of the lowest dose, 25 mg, up to about $650 for 30 capsules of the highest 200 mg dose. Since there is a generic version of topiramate available, many insurance plans will consider Trokendi XR a Tier 2 or 3 medication if it’s covered, meaning you’ll pay a higher co-pay. In contrast, generic topiramate is available from many pharmacies at under or around $20 for 60 tablets, depending on the strength, and will be covered by most insurance plans under the lowest tier or co-pay level.